Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular ketamine before venous cannulation in children
IRCT20240825062863N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in Intravenous cannulation (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Ease of venous cannulation. Started Oct 2024; status: completed.
02
Drugs
ketamine
03
Conditions
Intravenous cannulation
Beyond the preview
Go deeper on IRCT20240825062863N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240825062863N1.